| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |